Skip to main content
OpenTrials

Clinical trial condition

Osteoporosis

Explore clinical trials studying Osteoporosis. Study availability and eligibility vary by location and protocol.

171 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Osteoporosis trial results

Completed

A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

NCT00503113

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +5 more
Locations
  • Birmingham, Alabama, United States
  • Riverside, California, United States
  • Lakewood, Colorado, United States
  • West Palm Beach, Florida, United States
View all 44 locations
View Trial Details
Completed

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

NCT00343252

Conditions
Back Injuries, Back Pain, Bone Diseases, +15 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montgomery, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Peoria, Arizona, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Laguna Hills, California, United States
View all 72 locations
View Trial Details
Completed

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

NCT00130403

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations
  • sanofi-aventis, US Bridgewater, New Jersey, United States
  • sanofi-aventis, Australia Cove, New South Wales, Australia
  • sanofi-aventis, Belgium Diegem, Belgium
  • sanofi-aventis, Canada Laval, Quebec, Canada
View Trial Details
Completed

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

NCT00088010

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Elk Grove, Illinois, United States
View Trial Details
Completed

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

NCT00383422

Conditions
Bone Diseases, Bone Diseases, Metabolic, Metabolic Diseases, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gainesville, Georgia, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Urbandale, Iowa, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Billings, Montana, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States
View all 21 locations
View Trial Details

Related conditions